中华微生物学和免疫学杂志
中華微生物學和免疫學雜誌
중화미생물학화면역학잡지
CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY
2012年
5期
425-429
,共5页
刘雪瑶%吴迪%许杰%汪洋
劉雪瑤%吳迪%許傑%汪洋
류설요%오적%허걸%왕양
痘苗病毒%免疫优势%显性表位%细胞免疫%疫苗载体
痘苗病毒%免疫優勢%顯性錶位%細胞免疫%疫苗載體
두묘병독%면역우세%현성표위%세포면역%역묘재체
Vaccinia virus%Immunodominance%Dominant epitope%Cellular immunity%Vaccine vector
目的 去除B8R对外源抗原免疫原性的影响,为降低载体的免疫优势从而提高疫苗的有效性提供参考.方法 利用针对痘苗病毒的pSC11质粒,构建插入OVA的质粒pSC11-OVA,在CV-1细胞中与去除B8R的痘苗病毒重组,筛选纯化获得重组病毒.利用体外培养细胞,检测B8R缺失和外源抗原插入对病毒感染复制特性的影响;利用感染小鼠模型,检测重组病毒诱发的针对OVA的细胞免疫应答和免疫记忆效应;采用体征及神经行为学评分系统,检测重组病毒的毒力.结果 B8R缺失和OVA导入对痘苗病毒的生物学特性无明显影响;去除B8R后,外源性OVA成为显性表位,针对OVA的细胞免疫应答和免疫记忆效应明显增强;去除B8R还可显著降低痘苗病毒的毒力.结论 去除B8R可有效降低痘苗病毒的免疫优势效应,增加外源性抗原的免疫原性.去除痘苗病毒本身的显性表位,可为疫苗和基因治疗提供更为有效的载体.
目的 去除B8R對外源抗原免疫原性的影響,為降低載體的免疫優勢從而提高疫苗的有效性提供參攷.方法 利用針對痘苗病毒的pSC11質粒,構建插入OVA的質粒pSC11-OVA,在CV-1細胞中與去除B8R的痘苗病毒重組,篩選純化穫得重組病毒.利用體外培養細胞,檢測B8R缺失和外源抗原插入對病毒感染複製特性的影響;利用感染小鼠模型,檢測重組病毒誘髮的針對OVA的細胞免疫應答和免疫記憶效應;採用體徵及神經行為學評分繫統,檢測重組病毒的毒力.結果 B8R缺失和OVA導入對痘苗病毒的生物學特性無明顯影響;去除B8R後,外源性OVA成為顯性錶位,針對OVA的細胞免疫應答和免疫記憶效應明顯增彊;去除B8R還可顯著降低痘苗病毒的毒力.結論 去除B8R可有效降低痘苗病毒的免疫優勢效應,增加外源性抗原的免疫原性.去除痘苗病毒本身的顯性錶位,可為疫苗和基因治療提供更為有效的載體.
목적 거제B8R대외원항원면역원성적영향,위강저재체적면역우세종이제고역묘적유효성제공삼고.방법 이용침대두묘병독적pSC11질립,구건삽입OVA적질립pSC11-OVA,재CV-1세포중여거제B8R적두묘병독중조,사선순화획득중조병독.이용체외배양세포,검측B8R결실화외원항원삽입대병독감염복제특성적영향;이용감염소서모형,검측중조병독유발적침대OVA적세포면역응답화면역기억효응;채용체정급신경행위학평분계통,검측중조병독적독력.결과 B8R결실화OVA도입대두묘병독적생물학특성무명현영향;거제B8R후,외원성OVA성위현성표위,침대OVA적세포면역응답화면역기억효응명현증강;거제B8R환가현저강저두묘병독적독력.결론 거제B8R가유효강저두묘병독적면역우세효응,증가외원성항원적면역원성.거제두묘병독본신적현성표위,가위역묘화기인치료제공경위유효적재체.
Objective To investigate the antigenicity of foreign antigen in recombinant vaccinia virus (VACV) after elimination of B8R,and provide help to improve the efficacy of VACV-based vaccines,and provide guidance for vaccine design.Methods Transfer vector pSC11-OVA was generated,and OVAgene was in,rted into VACV with B8R deletion.The biological characteristics of recombinant VACV was investigated in vitro,and the immune responses against OVA were tested in vivo.Results The plague phenotypes and growth of wcombinant VACV and its parental strains were essentially identical.Cellular immuneresponse against OVA was augmented in mice infected with B8R-deleted recombinant VACV when comparedwith those infected with B8R-intact recombinant VACV.Conclusion Deletion of B8R and insertion of OVAdoes not affect the biological characteristics of VACV.Immunogenicity of exogenous target antigens can beimproved in VACV with B8R deficiency.Deletion of dominant epitopes may provide a vector with more efficiency for vaccines and gene therapy.